Allergy Relieving Eye Drops Market Global Forecast Report By Drug Class, Type, Countries And Company Analysis 2024-2032

Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Allergy Relieving Eye Drops Market Global Forecast Report by Drug Class, Type, Countries and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The Allergy-Relieving Eye Drops market is expected to grow from USD 1.51 billion in 2023 to USD 2.37 billion by 2032 at a CAGR of 5.15% from 2024 to 2032. Factors driving growth include growing demand for inexpensive, yet effective allergy relief, non-invasive procedures, strategic marketing, consumer education by key players, and advancements in the development and manufacture of these products.

Rising Prevalence of Allergies
Rising allergy rates in global markets serve as the major growth driver in the allergy-relieving eye drops market. Allergic reactions, including eye-related symptoms, have increased due to rising pollution, climate change, and urbanization levels. The increasing number of seasonal and perennial allergies is raising demand for effective eye treatments that are easy to administer and boost the allergy-relieving eye drops market. There is a rapidly increasing trend of allergic diseases all over the world, and almost 30-40% of the world's population is suffering from one or more allergic disorders.
Demand for Non-Invasive, Convenient Solutions
Consumers are also becoming increasingly interested in non-invasive, quick relief for their allergy symptoms. Relief from discomfort without oral medications or injections is attainable through allergy-relieving eye drops. The market sustains further growth through the trend toward over-the-counter access as patients seek convenient means to address allergies. In August 2024, OCuSOFT Inc. introduces NEW OCuSOFT Retaine Allergy, prescription-strength antihistamine drops for dry eye itch relief.
Advancements in Eye Drop Formulations
Ongoing research and revolution in eye care have improved the formulations for allergic eye drops, reducing the allergy by effectiveness and comfort. New formulas attract more consumers, having longer effects, with fewer side effects, and faster relief from eye allergy, hence offering better results with fewer applications. It is the innovation, that in a way fuels market expansion due to a demand from highly effective user-friendly solutions. The eye care leader, Alcon, will present new clinical data and innovation in products at AAO 2024 Annual Meeting in Oct 2024.
Canada Allergy Relieving Eye Drops Market
The demand for Canada allergy-relieving eye drops is rising due to the prevalence of seasonal and environmental allergens in many parts of the country. A higher incidence of urbanization, climatic changes, and air pollution are responsible for raising the allergic level and thus triggering a necessity for more efficient OTC eye treatments. Tens of millions of Canadians are in search of immediate, speedy relief from redness, itchiness, and swelling, which is increasing the demand of the allergy-relieving eye drops market. In addition, development of eye drop formulations and non-invasive treatment solutions are attracting more and more consumers. In addition to that, marketing efforts from major pharmaceutical companies also support growth in this Canadian market. Feb 2021, Bausch + Lomb announced the U.S. launch of Alaway Preservative Free eye drops, the first OTC preservative-free antihistamine approved by the FDA for eye itch relief.
France Allergy Relieving Eye Drops Market
Rising allergies related to environmental changes, urbanization, and pollution are further increasing the allergy-relieving eye drops market in France. Seasonal allergic tendencies are on the rise, especially in urban areas. There is a significantly growing demand for easily accessible, over-the-counter eye drops that will immediately alleviate itching, redness, and irritation. French consumers prefer non-invasive options and favor allergy-relieving eye drops as an easy-to-use solution. Advancements in the formulations of eye drops that sustain longer than conventional varieties and cause more comfort to add up towards market growth as giant pharmaceutical companies keep on innovating with products of viable treatment options across the country.
India Allergy Relieving Eye Drops Market
India's allergy-relieving eye drops market is growing since the escalating levels of pollution, urbanization, and changing climate have made people develop allergic reactions. Many Indians suffer from eye allergic symptoms, most predominantly in thickly populated cities. This creates a massive demand for efficient, non-prescription eye drops that alleviate itching, redness, and irritation. Consumers are increasingly in pursuit of convenient and non-invasive treatments, and the allergy-relieving eye drops is one such quick and easily accessible solution.

With the recent progress in eye drop formulations and increased awareness through marketing initiatives from major pharmaceuticals in India, this market is expected to grow further. In September 2024: PresVu eye drops from ENTOD Pharmaceuticals were approved by the Drugs Controller General of India (DCGI). PresVu is an eye drop that would reduce the dependence on reading glasses for presbyopia patients. A common condition affecting most people above 40, this causes the victim to have difficulty focusing on close objects. PresVu stands as a benchmark in the eye care space for the elderly.
UAE Allergy Relieving Eye Drops Market
The allergy cases rise up in UAE with the dust level being high and the arid climate plus rapid urbanization. Eye allergies in the UAE are more common because of frequent sandstorms, and because of an affinity for the use of air conditioning, which exacerbates dryness, itchiness, and redness. There is a further increase in demand due to over-the-counter eye drops that immediately provide relief with non-invasive features, which are effective. Another factor that pushes the demand upward is further consciousness about allergy management as well as formulations of eye drops, such as prolonged-acting relief as well as greater comfort, driving demand higher because customers want easier fixes for eye allergy symptoms.

Company Analysis

• AbbVie Inc. (Allergan Plc)
• Johnson & Johnson
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Bausch Health Companies Inc
• Regeneron Pharmaceuticals
• Santen Pharmaceutical Co
  • Overview
  • Key Persons
  • Recent Development & Strategies
  • Product Portfolio
  • Financial Insights

Key Attributes:

Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Allergy Relieving Eye Drops Market
6. Market Share Analysis
6.1 Drug Class
6.2 Type
6.3 Country
7. Drug Class
7.1 Antihistamines
7.2 Non-steroidal anti-Inflammatory Drugs
7.3 Vasoconstrictors
7.4 Others
8. Type
8.1 Seasonal and Perennial Allergic Conjunctivitis
8.2 Vernal Keratoconjunctivitis
8.3 Atopic Keratoconjunctivitis
8.4 Giant Papillary Conjunctivitis
8.5 Others
9. Country
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherlands
9.2.8 Turkey
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 South Korea
9.3.6 Thailand
9.3.7 Malaysia
9.3.8 Indonesia
9.3.9 New Zealand
9.4 Latin America
9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina
9.5 Middle East & Africa
9.5.1 South Africa
9.5.2 Saudi Arabia
9.5.3 UAE
10. Porter's Five Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Allergy Relieving Eye Drops Market

MENAFN27112024004107003653ID1108932727